News Archive

Most office buildings around the country have remained empty over the past year as companies quickly pivoted to working remotely to help slow the pandemic’s spread. However, many office campuses owned by office real estate investment trust (REIT) Alexandria Real Estate Equities (NYSE: ARE) have been buzzing with activity during the outbreak. That’s because many of its tenants have been working around the clock waging war against the virus, and they needed the company’s specialized lab space to develop solutions aimed at defeating the pandemic.

NEW YORK–(BUSINESS WIRE)–Avoro Ventures announced today that Sara Nayeem, MD, has joined the firm as a Partner, focused on its venture capital investment efforts.

Dr. Nayeem joins Avoro Ventures after 12 years with New Enterprise Associates, Inc. (NEA), where she was a Partner in the firm’s biopharma investment practice serving on numerous company boards, in addition to providing support to fundraising, recruiting, and diversity and mentoring initiatives. She will source and manage private market investments within the biotechnology sector spanning early stage to late stage and cross-over, joining Behzad Aghazadeh, PhD, Managing Partner of Avoro Ventures and Avoro Capital Advisors, and Dr. Garheng Kong, Avoro Ventures Advisory Partner.

As a follow up to our last event Pitch Perfect: Communicating with Investors Before AND After Funding, we’re excited to bring you Pitch Perfect II: In Action.

We’ll be showcasing four startups from the SoPE and GW community. Each will give a 10 minute pitch followed by a 5 minute Q&A to our panel of experienced venture capital and angel investors.

Join the conversation with Emily Durfee, Program Manager at Healthworx, the innovation and investment arm of CareFirst. Healthworx’ Challenge focuses on improving health equity at the community level .Learn about Healthworx’ mission and vision, as Emily shares insights, answer questions and explains the intention of this terrific opportunity to connect with a very important leader in Maryland’s healthcare and innovation community.

Something of the dark horse in the race to get a COVID-19 vaccine out to the public, Novavax announced a Memorandum of Understanding (MOU) with Gavi, the Vaccine Alliance, to provide 1.1 billion doses of NVX-CoV2373, its COVID-19 vaccine candidate, for the COVAX Facility. The vaccine will be manufactured and distributed around the world by Novavax and Serum Institute of India (SII). SII has an existing deal with Gavi.

Image: https://www.biospace.com

NEW YORK – Qiagen on Thursday said that it has launched a “Digital Insights Partnership” program designed to expand the market for its bioinformatics products through various third-party collaborations and deals.

The Montgomery County biotech joins a handful of other local companies to recently debut on the public markets.